REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 134 filers reported holding REPLIMUNE GROUP INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,919,139 | +90.6% | 813,509 | +158.7% | 0.00% | +50.0% |
| Q2 2023 | $7,301,018 | +380.6% | 314,428 | +265.5% | 0.00% | – |
| Q1 2023 | $1,519,078 | -11.1% | 86,018 | +36.9% | 0.00% | – |
| Q4 2022 | $1,709,330 | +18.0% | 62,843 | -25.1% | 0.00% | – |
| Q3 2022 | $1,449,000 | +240.9% | 83,903 | +245.3% | 0.00% | – |
| Q2 2022 | $425,000 | -49.0% | 24,300 | -50.5% | 0.00% | – |
| Q1 2022 | $833,000 | -75.2% | 49,072 | -60.4% | 0.00% | – |
| Q4 2021 | $3,358,000 | +174.6% | 123,948 | +200.4% | 0.00% | – |
| Q3 2021 | $1,223,000 | -60.7% | 41,267 | -49.1% | 0.00% | – |
| Q2 2021 | $3,114,000 | +22.8% | 81,064 | -2.5% | 0.00% | – |
| Q1 2021 | $2,536,000 | -35.0% | 83,143 | -18.8% | 0.00% | – |
| Q4 2020 | $3,904,000 | – | 102,334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 5,344,971 | $122,395,000 | 33.11% |
| Corriente Advisors, LLC | 512,500 | $11,798,000 | 5.98% |
| Bain Capital Life Sciences Investors, LLC | 2,122,415 | $48,858,000 | 4.55% |
| BVF INC/IL | 1,691,834 | $38,946,000 | 2.12% |
| Redmile Group, LLC | 3,330,999 | $76,680,000 | 1.41% |
| EMERALD ADVISERS, LLC | 891,761 | $20,528,000 | 0.84% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 823,989 | $18,968,000 | 0.84% |
| Penn Mutual Asset Management, LLC | 15,877 | $365,000 | 0.52% |
| EAM Global Investors LLC | 54,274 | $1,249,000 | 0.46% |
| Artal Group S.A. | 700,000 | $16,114,000 | 0.39% |